摘要:
A method for pre-accessing a conference telephone is disclosed in the present invention. The method includes that: a network side detects a received call whose target is a main control party after the main control party initiates an encryption conference telephone; the call is not accessed if the call is a non-encryption conversation; the call is allowed to be accessed if the call is an encryption conversation. A system for pre-accessing a conference telephone is also disclosed in the present invention, wherein, the system includes a pre-accessing processing unit and a call type detection unit of the network side. A network side device is also disclosed in the present invention. The present invention realizes the pre-accessing of the encryption conference telephone, thereby improving security of the encryption conversation as well as avoiding the problem that a user is frequently affected when performing the encryption conference telephone.
摘要:
A clock generator utilized for providing a clock signal includes: a first oscillator and a switching circuit. The switching circuit is coupled to the first oscillator and a second oscillator, and utilized for receiving a first oscillating signal generated from the first oscillator and a second oscillating signal generated from the second oscillator, and selecting one of the first oscillating signal and the second oscillating signal as the clock signal according to a status signal.
摘要:
Embodiments relate to serological markers for detecting the colorectal cancer and applications of the serological markers. A phospholipid scramblase1 (PLSCR1), a stomatin-like protein 2 (STOML2) or a transport protein Sec61β (SEC61β) increases expression in the blood at the earlier stage of the colorectal cancer. Detecting the expression of the PLSCR1, STOML2 or SEC61β protein or an induced autoantibody of each protein in a blood sample is used to diagnose the colorectal cancer. Moreover, the serological marker improves the detection efficiency and the sensitivity in detecting the colorectal cancer and is used to predict the prognosis. The serological markers are applied in preparing a detection device or inhibiting the growth of the colorectal cancer cells.
摘要:
The present invention discloses an oral cancer biomarker and an inspection method using the same. The biomarker is Mca-2 binding protein (Mac-2BP), which can be directly detected in the specimen of the body fluid of a testee, and which can realize a fast and effective clinical diagnosis of oral cancer.
摘要:
A digital PLL frequency synthesizer characterized by fast-locking and low-jitters is presented. The PLL comprises a phase detector, a controllable oscillator, a loop filter having an automatically-adjusted loop gain, a feedback phase integration circuit, and a reference phase integration circuit. Fast-locking is achieved by dynamically adjusting forward-path gain and integral-path gain according to the output of the phase detector and the output of the integral-path during phase tracking. A skew-compensated counter circuit is proposed, which incorporates an asynchronous counter, a data register and a sample phase generator and features high-speed and low-power operation.
摘要:
A network device for processing data on a data network includes a port interface, in communication with a plurality of ports, configured to receive a data packet from a data network and assign an ingress interface number to the data packet and a packet evaluation module, in communication with the port interface, configured to parse the received data packet and modify the received data packet, if needed based on the ingress interface number. The port interface assigns the ingress interface number based on at least one of a port of the plurality of ports upon which the data packet was received and a virtual local area network through which the data packet was received.
摘要:
The present invention provides a sulfated polysaccharide (D-HG), a pharmaceutically acceptable salt thereof, a process for preparing the same and a medicament containing the same as the effective component for DIC (disseminated intravascular coagulation) and thrombosis, the sulfated polysaccharide (D-HG) being prepared by depolymerization of FGAG (a sulfated polysaccharide extracted from a body wall of a sea cucumber with such activities as those of heparin) or a salt thereof and having the following physicochemical properties:[1] Molecular weight:3,000 to 42,000 (as measured by high performance GPC)[2] Characteristic:white, amorphous, highly hygroscopic powder[3] Solubility:soluble in water but insoluble in ethanol, acetone and like organic solvents[4] Specific rotation:[.alpha.].sub.D.sup.20 =-55 to -73.degree. (C=1%)[5] Color reaction: as shown below______________________________________ Elson-Morgan reaction + Carbazole-sulfuric acid reaction + Cystein-sulfuric acid reaction + Orcinol-hydrochloric acid reaction + Azure A metachromasia reaction + ______________________________________ [6] Analysis for composition: as shown belowGalactosamine: Glucuronic acid: Fucose: sulfate=1:0.8.+-.0.2:0.85.+-.0.15:3.4.+-.0.9.
摘要:
A server includes a motherboard, a first test unit, and an indication device. The first test unit is connected to a first voltage terminal of the motherboard to receive a first voltage. The first test unit determines whether the received first voltage is within a range between a first predetermined voltage and a second predetermined voltage. If the first voltage is not within the range between the first predetermined voltage and the second predetermined voltage, the indication device indicates that the first voltage is abnormal.
摘要:
A server includes a motherboard, a first test unit, and an indication device. The first test unit is connected to a first voltage terminal of the motherboard to receive a first voltage. The first test unit determines whether the received first voltage is within a range between a first predetermined voltage and a second predetermined voltage. If the first voltage is not within the range between the first predetermined voltage and the second predetermined voltage, the indication device indicates that the first voltage is abnormal.
摘要:
A bladder cancer biomarker and a test method using the same are provided. The biomarker contains serum amyloid A-4 protein (SAA4), which exist in the urine specimen of a testee. The expression intensity of the biomarker can facilitate diagnosis of bladder cancer and evaluation of aggressiveness and malignancy of bladder cancer. Thereby, the physician can arrange an optimized treatment to achieve the best therapeutic effect.